1st Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Firm
Client
Income
$46,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Ballistic Missile Defense Organization; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); White House Office; Defense, Dept of (DOD); Food & Drug Administration (FDA); Army, Dept of (Other); SENATE; Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Defense Threat Reduction Agency (DTRA)

Homeland Security HOM

Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Ballistic Missile Defense Organization; Defense Threat Reduction Agency (DTRA); Homeland Security, Dept of (DHS); Army, Dept of (Other); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Army, Dept of (Other); Defense Threat Reduction Agency (DTRA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Defense, Dept of (DOD); Homeland Security, Dept of (DHS); Ballistic Missile Defense Organization; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.